BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34942305)

  • 1. SETD8 stabilized by USP17 epigenetically activates SREBP1 pathway to drive lipogenesis and oncogenesis of ccRCC.
    Li X; Liu Z; Xia C; Yan K; Fang Z; Fan Y
    Cancer Lett; 2022 Feb; 527():150-163. PubMed ID: 34942305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E2F1 promotes proliferation and metastasis of clear cell renal cell carcinoma via activation of SREBP1-dependent fatty acid biosynthesis.
    Shen D; Gao Y; Huang Q; Xuan Y; Yao Y; Gu L; Huang Y; Zhang Y; Li P; Fan Y; Tang L; Du S; Wu S; Wang H; Wang C; Gong H; Pang Y; Ma X; Wang B; Zhang X
    Cancer Lett; 2021 Aug; 514():48-62. PubMed ID: 34019961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer.
    Wada M; Kukita A; Sone K; Hamamoto R; Kaneko S; Komatsu M; Takahashi Y; Inoue F; Kojima M; Honjoh H; Taguchi A; Kashiyama T; Miyamoto Y; Tanikawa M; Tsuruga T; Mori-Uchino M; Wada-Hiraike O; Osuga Y; Fujii T
    Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33339442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of the AMPK-GATA3-ECHS1 Pathway Induces Fatty Acid Synthesis That Promotes Clear Cell Renal Cell Carcinoma Growth.
    Qu YY; Zhao R; Zhang HL; Zhou Q; Xu FJ; Zhang X; Xu WH; Shao N; Zhou SX; Dai B; Zhu Y; Shi GH; Shen YJ; Zhu YP; Han CT; Chang K; Lin Y; Zang WD; Xu W; Ye DW; Zhao SM; Zhao JY
    Cancer Res; 2020 Jan; 80(2):319-333. PubMed ID: 31690668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of sterol regulatory element-binding protein 1 (SREBP1)-mediated lipogenesis by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma.
    Lo AK; Lung RW; Dawson CW; Young LS; Ko CW; Yeung WW; Kang W; To KF; Lo KW
    J Pathol; 2018 Oct; 246(2):180-190. PubMed ID: 29968360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SETD8 potentiates constitutive ERK1/2 activation via epigenetically silencing DUSP10 expression in pancreatic cancer.
    Liu M; Qin Y; Hu Q; Liu W; Ji S; Xu W; Fan G; Ye Z; Zhang Z; Xu X; Yu X; Zhuo Q
    Cancer Lett; 2021 Feb; 499():265-278. PubMed ID: 33232789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SETD8 promotes stemness characteristics and is a potential prognostic biomarker of gastric adenocarcinoma.
    Piao L; Che N; Li H; Li M; Feng Y; Liu X; Kim S; Jin Y; Xuan Y
    Exp Mol Pathol; 2020 Dec; 117():104560. PubMed ID: 33127342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The PPARγ-SETD8 axis constitutes an epigenetic, p53-independent checkpoint on p21-mediated cellular senescence.
    Shih CT; Chang YF; Chen YT; Ma CP; Chen HW; Yang CC; Lu JC; Tsai YS; Chen HC; Tan BC
    Aging Cell; 2017 Aug; 16(4):797-813. PubMed ID: 28514051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The histone lysine methyltransferase SETD8 regulates angiogenesis through HES-1 in human umbilical vein endothelial cells.
    Choi DK; Kim YK; Park SW; Lee H; Lee S; Kim SA; Kim SJ; Lee J; Kim W; Min SH; Yu JH
    Sci Rep; 2020 Jul; 10(1):12089. PubMed ID: 32694555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic Determinants of Erythropoiesis: Role of the Histone Methyltransferase SetD8 in Promoting Erythroid Cell Maturation and Survival.
    DeVilbiss AW; Sanalkumar R; Hall BD; Katsumura KR; de Andrade IF; Bresnick EH
    Mol Cell Biol; 2015 Jun; 35(12):2073-87. PubMed ID: 25855754
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Su X; Zhang J; Mouawad R; Compérat E; Rouprêt M; Allanic F; Parra J; Bitker MO; Thompson EJ; Gowrishankar B; Houldsworth J; Weinstein JN; Tost J; Broom BM; Khayat D; Spano JP; Tannir NM; Malouf GG
    Cancer Res; 2017 Sep; 77(18):4835-4845. PubMed ID: 28754676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma.
    Zhou J; Deng Z; Chen Y; Gao Y; Wu D; Zhu G; Li L; Song W; Wang X; Wu K; He D
    Urol Oncol; 2015 Mar; 33(3):113.e9-17. PubMed ID: 25192834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SREBP1 regulates tumorigenesis and prognosis of pancreatic cancer through targeting lipid metabolism.
    Sun Y; He W; Luo M; Zhou Y; Chang G; Ren W; Wu K; Li X; Shen J; Zhao X; Hu Y
    Tumour Biol; 2015 Jun; 36(6):4133-41. PubMed ID: 25589463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma.
    Calvisi DF; Wang C; Ho C; Ladu S; Lee SA; Mattu S; Destefanis G; Delogu S; Zimmermann A; Ericsson J; Brozzetti S; Staniscia T; Chen X; Dombrowski F; Evert M
    Gastroenterology; 2011 Mar; 140(3):1071-83. PubMed ID: 21147110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPX8 regulates clear cell renal cell carcinoma tumorigenesis through promoting lipogenesis by NNMT.
    Nguyen TTM; Nguyen TH; Kim HS; Dao TTP; Moon Y; Seo M; Kang S; Mai VH; An YJ; Jung CR; Kim JM; Park S
    J Exp Clin Cancer Res; 2023 Feb; 42(1):42. PubMed ID: 36750850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SETD8 induces stemness and epithelial-mesenchymal transition of pancreatic cancer cells by regulating ROR1 expression.
    Liu M; Shi Y; Hu Q; Qin Y; Ji S; Liu W; Zhuo Q; Fan G; Ye Z; Song C; Yu X; Xu X; Xu W
    Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1614-1624. PubMed ID: 34599596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression.
    Takawa M; Cho HS; Hayami S; Toyokawa G; Kogure M; Yamane Y; Iwai Y; Maejima K; Ueda K; Masuda A; Dohmae N; Field HI; Tsunoda T; Kobayashi T; Akasu T; Sugiyama M; Ohnuma S; Atomi Y; Ponder BA; Nakamura Y; Hamamoto R
    Cancer Res; 2012 Jul; 72(13):3217-27. PubMed ID: 22556262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SREBP-1c as a molecular bridge between lipogenesis and cell cycle progression of clear cell renal carcinoma.
    Sethi G; Shanmugam MK; Kumar AP
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29138263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SETD8 involved in the progression of inflammatory bowel disease via epigenetically regulating p62 expression.
    Chen P; Zhu H; Mao Y; Zhuo M; Yu Y; Chen M; Zhao Q; Li L; Wu M; Ye M
    J Gastroenterol Hepatol; 2021 Oct; 36(10):2850-2863. PubMed ID: 33991018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SREBP1-driven lipid desaturation supports clear cell renal cell carcinoma growth through regulation of NF-κB signaling.
    Yang H; Zhang X; Liu F; Fan J; Wang B; Dong C
    Biochem Biophys Res Commun; 2018 Jan; 495(1):1383-1388. PubMed ID: 29183723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.